Items where authors include "Ramasamy, K."

Article

Mehta, D., Cicero, R., Chiecchio, L. et al. (10 more authors) (2025) Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study. eJHaem, 6 (3). e1015. ISSN 2688-6146

Agarwal, G., Moore, S., Sadler, R. et al. (21 more authors) (2024) Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma. Haematologica. ISSN 0390-6078

Mitchell, J.L., Khan, D., Rana, R.H. et al. (10 more authors) (2023) Multiple myeloma and its treatment contribute to increased platelet reactivity. Platelets, 34 (1). 2264940. ISSN 0953-7104

Twumasi, C. orcid.org/0000-0001-6817-8356, Moore, S. orcid.org/0000-0003-1380-1934, Sadler, R. orcid.org/0000-0003-2250-670X et al. (20 more authors) (2023) Determinants of durable humoral and T cell immunity in myeloma patients following <scp>COVID</scp>‐19 vaccination. European Journal of Haematology. ISSN 0902-4441

Gooding, S., Lau, I.-J., Sheikh, M. et al. (7 more authors) (2015) Double relapsed and/or refractory multiple myeloma : clinical outcomes and real world healthcare costs. PLoS ONE, 10 (9). e0136207.

Conference or Workshop Item

Gooding, S., Royle, K.-L. orcid.org/0000-0003-0225-1199, Kazeroun, M. et al. (28 more authors) (2024) Risk Assignment Using the Myeloma Genome Project Panel: A Comparison to Standard of Care Genetic Testing within the UK-MRA RADAR Trial. In: The 66th ASH Annual Meeting, 07-10 Dec 2024, San Diego, California, United States.